#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15614	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2104	738.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1447	1447	C	926	C	855	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15614	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2104	738.3	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1675	1675	T	871	TGGGGG,TGGGGGG	586,185	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15614	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2104	738.3	0	HET	.	.	.	C1525T	.	1525	1525	C	1788	1788	C	798	C,T	539,194	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28528	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3503	811.3	0	.	n	.	0	T695C	SNP	695	695	T	933	933	C	860	C	801	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28528	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3503	811.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	1876	1876	G	926	G,C,A,T	856,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28528	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3503	811.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2209	2209	C	908	C	822	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28528	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3503	811.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2283	2283	A	867	A	816	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28528	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3503	811.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2835	2835	C	929	C,T	861,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28528	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3503	811.3	0	HET	.	.	.	A20C	.	20	20	A	258	258	A	673	A,C	395,230	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2166	folP	855	855	100.0	folP.l6.c30.ctg.1	1578	136.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1064	1066	AGC	205;203;202	A;G;C	190;189;186	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5604	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3321	168.2	1	SNP	p	S91F	1	.	.	271	273	TTC	518	520	TTC	213;216;214	T;T;C	196;202;198	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5604	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3321	168.2	1	SNP	p	G95N	0	.	.	283	285	GGC	530	532	GGC	214;214;210	G;G;C,A	200;198;193,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5604	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3321	168.2	1	SNP	p	D95G	1	.	.	283	285	GGC	530	532	GGC	214;214;210	G;G;C,A	200;198;193,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1662	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1236	133.9	0	.	p	.	0	F184L	NONSYN	550	552	TTC	878	880	TTG	192;193;194	T;T;G	174;174;176	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1662	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1236	133.9	1	SNP	p	G45D	0	.	.	133	135	GGC	461	463	GGC	219;219;217	G;G;C	199;198;197	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	806	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	954	83.9	0	.	n	.	0	A197.	DEL	197	197	A	571	571	A	185	A	175	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5584	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2891	192.2	1	SNP	p	D86N	0	.	.	256	258	GAC	568	570	GAC	244;241;242	G;A;C,T	220;216;218,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5584	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2891	192.2	1	SNP	p	R87I	0	.	.	259	261	CGT	571	573	CGT	242;241;244	C;G;T	221;219;220	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5584	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2891	192.2	1	SNP	p	R87W	0	.	.	259	261	CGT	571	573	CGT	242;241;244	C;G;T	221;219;220	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5584	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2891	192.2	1	SNP	p	S87R	1	.	.	259	261	CGT	571	573	CGT	242;241;244	C;G;T	221;219;220	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5584	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2891	192.2	1	SNP	p	S88P	0	.	.	262	264	TCC	574	576	TCC	246;247;245	T;C;C	222;224;221	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4614	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2605	176.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1563	1565	GGC	228;229;224	G;G;C	200;199;193	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4178	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	176.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1199	1201	GCA	222;222;223	G;C;A	204;200;202	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4178	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	176.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1202	1204	ATC	228;228;228	A;T;C	203;206;208	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4178	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	176.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1214	1216	GTG	227;230;230	G;T;G	210;211;212	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4178	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	176.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1214	1216	GTG	227;230;230	G;T;G	210;211;212	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4178	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	176.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1718	1720	ACC	234;232;233	A,G;C;C	210,1;215;215	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4178	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	176.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1772	1774	GCG	231;233;230	G;C,G;G	199;184,1;196	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4178	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	176.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1772	1774	GCG	231;233;230	G;C,G;G	199;184,1;196	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4178	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	176.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1895	1897	AGC	200;196;195	A;G,T;C	184;181,1;180	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4178	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	176.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1904	1906	GGC	192;193;193	G;G;C	175;176;175	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4178	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	176.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1922	1924	CCG	165;169;169	C,G;C,G;G	116,8;123,1;123	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5828	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3293	176.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1729	1731	CCG	221;223;218	C;C,A,T;G	197;203,1,1;197	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	6618	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1717	381.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	443	443	C	477	C	438	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2850	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1555	182.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	477	479	GAA	238;235;232	G;A,G;A	222;223,1;221	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2850	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1555	182.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	765	767	GAT	216;216;216	G;A;T	196;195;196	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2850	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1555	182.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	888	890	TCA	234;234;232	T;C;A	218;221;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2850	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1555	182.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1017	1019	GTC	244;246;244	G;T;C	226;230;230	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2850	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1555	182.5	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1029	1031	TCT	251;250;248	T;C;T	239;236;236	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2850	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1555	182.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1347	1349	GCA	237;237;237	G;C;A	218;217;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2850	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1555	182.5	1	SNP	p	G120K	1	.	.	358	360	AAG	723	725	AAG	210;207;205	A;A;G	197;194;192	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2850	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1555	182.5	1	SNP	p	A121D	1	.	.	361	363	GAC	726	728	GAC	202;201;202	G;A;C	191;188;191	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2850	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1555	182.5	1	SNP	p	D121N	0	.	.	361	363	GAC	726	728	GAC	202;201;202	G;A;C	191;188;191	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11292	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4929	228.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1168	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	867	133.6	1	SNP	p	V57M	1	.	.	169	171	ATG	429	431	ATG	256;256;256	A;T,C;G	235;233,1;234	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
